GILD
Gilead Sciences, Inc.
Stock
$149.05−2.23 (−1.47%)Close Sep 30, 2026
| Total assets (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $49.4B | −11.4% | −2.9% | 1.3% |
| Total assets (Q2 2026) | $49.4B |
|---|---|
| YoY | −11.4% |
| 5-year CAGR | −2.9% |
| 10-year CAGR | 1.3% |
Total assets
| Period | Total assets | YoY |
|---|---|---|
| 2025 | $59.0B | 0.0% |
| 2024 | $59.0B | −5.0% |
| 2023 | $62.1B | −1.7% |
| 2022 | $63.2B | −7.0% |
| 2021 | $68.0B | −0.7% |
| 2020 | $68.4B | +11.0% |
| 2019 | $61.6B | −3.2% |
| 2018 | $63.7B | −9.4% |
| 2017 | $70.3B | +23.4% |
| 2016 | $57.0B | +10.2% |
| 2015 | $51.7B | +49.2% |
| 2014 | $34.7B | +53.5% |
| 2013 | $22.6B | +6.3% |
| 2012 | $21.2B | +22.8% |
| 2011 | $17.3B | +49.3% |
| 2010 | $11.6B | +19.5% |
| 2009 | $9.7B | +39.8% |
| 2008 | $6.9B | — |